Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Dexamethason phosphate sodium | Manufacture date | Mar.13.2025 |
Batch number | SW250313 | Analysis date | Mar.14.2025 |
Batch quantity | 100kg | Expire date | Mar.13.2027 |
Item | Specification | Results |
Appearance | White or almost white,very hygroscopic powder | conform |
Solubility | Freely soluble in water, slightly soluble in ethanol (96 percent) | conform |
Appearance of Solution | Not more intensely coloured than reference solution B7 | conform |
Identification | ||
IR | The spectrum should be accord to the dexamethason sodiumphosphate CRS | conform |
TLC | The principal spot in the chromatogram obtained with test solution is similar in position and size to the principal spot in the chromatogram obtained with reference solution. | conform |
Identification | ||
Ph | 7.5~9.5 | 8.7 |
Specific Optical Rotation | +75°~+83° | +77.5° |
Related substances | Impurity A< 0.5% | Not detected |
Impurity B< 0.5% | 0.05% | |
Total impurities<1.0% | 0.79% | |
Ethanol and Water | <13.0% | 8.6% |
Content | 97.0 per cent to 103.0 per cent (anhydrous substance). | 99.6% |
Packing description: | Sealed export grade drum & double of sealed plastic bag |
Storage: | Store in a tightly closed container ,in a cool and dry place |
Shelf life: | 2 years when properly stored |
Similiar product recommendation | |||
Capecitabine | Everolimus | Afatinib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Cediranib |
Cabozantinib | Selumetinib | Cetilistat | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Ponatinib |